Anzeige
Mehr »
Login
Sonntag, 16.02.2025 Börsentäglich über 12.000 News von 686 internationalen Medien
1,5 Mio. Unzen indiziert, 5,2 Mio. Unzen geschätzt - und es wächst weiter: Die Goldaktie mit neuem Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 18.09.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
18.09.24Rekordbeschäftigung in der Türkei - Historischer Höchststand erreicht 15,9 Millionen-
18.09.24Leistungsbilanzdefizit in der Türkei wächst im August-
18.09.2427 Milliardäre aus der Türkei auf der Forbes-Liste - Wer steht an der Spitze?-
18.09.24EUROPACORP: Capital increase following the allocation of free shares to EuropaCorp employees-
18.09.24LNA SANTE: 2024 half-year results-
18.09.24SUMMERSET GROUP HOLDINGS LIMITED: Application for quotation of securities - SNZ-
18.09.24SKY NETWORK TELEVISION LIMITED: Update - Dividend/Distribution - SKT-
18.09.24HEARTLAND GROUP HOLDINGS LIMITED: Application for quotation of securities - HGH-
18.09.24ECHELON RESOURCES LIMITED: 2024 AGM DIRECTOR NOMINATION WINDOW CLOSING-
18.09.24FLETCHER BUILDING LIMITED: Notice of 2024 Annual Shareholders Meeting-
18.09.24Bipartisan telehealth extension bill passes in House committee-
18.09.24NanoXplore Inc.: NanoXplore Reports Results for Its Q4-2024 and Full Year 2024380MONTREAL, Sept. 18, 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. ("NanoXplore" or "the Corporation") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for...
► Artikel lesen
18.09.24Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)94NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
► Artikel lesen
18.09.24Fanhua Inc.: Fanhua Reports First Half 2024 Unaudited Financial Results190GUANGZHOU, China, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Fanhua Inc. (Nasdaq: FANH) (the "Company" or "Fanhua"), a leading independent financial services provider in China, today announced its unaudited...
► Artikel lesen
18.09.24Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance53NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (the "Company") (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the...
► Artikel lesen
18.09.24Nanobiotix S.A.: NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results296RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3 may prime the immune...
► Artikel lesen
18.09.24E.C.D. Automotive Design: ECD Auto Design Announces CFO Transition and Board Restructure213KISSIMMEE, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq: ECDA) ("ECA Auto Design" or the "Company"), an industry leader in delivering restored, modified and electrified...
► Artikel lesen
18.09.24SciSparc Ltd: SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment195Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel...
► Artikel lesen
18.09.24Steelcase Inc.: Steelcase Reports Second Quarter Fiscal 2025 Results141Strong results compared to prior year including: Operating income increased $49 millionAdjusted operating income increased $15 millionGross margin improved 130 basis pointsTotal liquidity strengthened...
► Artikel lesen
18.09.24QIAGEN N.V.: QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform541Venlo, the Netherlands, Sept. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an important milestone with the launch of 100 new assays for its digital...
► Artikel lesen
Seite:  Weiter >>